Racial differences in takotsubo cardiomyopathy outcomes in a large nationwide sample

被引:29
|
作者
Zaghlol, Raja [1 ]
Dey, Amit K. [2 ]
Desale, Sameer [3 ]
Barac, Ana [4 ]
机构
[1] Georgetown Univ, MedStar Washington Hosp Ctr, Div Internal Med, Washington, DC USA
[2] NHLBI, Sect Inflammat & Cardlometab Dis, Bldg 10, Bethesda, MD 20892 USA
[3] MedStar Hlth Res Inst, Biostat & Biomed Informat Dept, Hyattsville, MD USA
[4] MedStar Washington Hosp Ctr, MedStar Heart & Vasc Inst, 110 Irying St NW,Ste 1218, Washington, DC 20010 USA
来源
ESC HEART FAILURE | 2020年 / 7卷 / 03期
关键词
Takotsubo cardiomyopathy; Stress-induced cardiomyopathy; Race; In-hospital outcomes; HEALTH DISPARITIES; ETHNIC-DIFFERENCES; STRESS; RACE; PREDICTORS; MORTALITY;
D O I
10.1002/ehf2.12664
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Takotsubo cardiomyopathy (TC) is characterized by transient ventricular impairment, often preceded by emotional or physical stress. Racial differences affect the outcomes of several cardiovascular conditions; however, the effect of race on TC remains unknown. This investigation aims to assess the effect of race on in-hospital outcomes of TC in a large national sample. Methods and results We conducted a US-wide analysis of TC hospitalizations from 2006 to 2014 by querying the National Inpatient Sample database for the International Classification of Diseases-ninth Revision TC code, characteristics, and inpatient outcomes. Patients with a primary diagnosis of acute coronary syndrome were excluded to reduce selection bias. Caucasians were compared with African Americans (AA) for differences in baseline characteristics and in-hospital outcomes. Multivariate regression models were created to adjust for potential confounders. Of 97 650 TC patients, 83 807 (86.9%) were women, 89 624 (91.8%) identified as Caucasians, and 8026 (8.2%) as AA. The annual number of TC hospitalizations increased significantly from 2006 to 2014 in both races (from 335 to 21 265 annual cases, P < 0.001). In-hospital mortality initially increased (1-2% in 2006 to 5-6% in 2009, P < 0.001) and subsequently remained relatively stable around 5-7% with no significant difference between races. In unadjusted analysis, AA had more cardiac arrests [304 (3.8%) vs. 2569 (2.9%), P = 0.04], invasive mechanical ventilation [1671 (20.8%) vs. 15 897 (17.7%), P = 0.002], tracheostomies [242 (3%) vs. 1600 (1.8%), P = 0.001], acute kidney injuries [1765 (22%) vs. 14 608 (16.3%), P < 0.0001], and longer hospital stays [4.5 (3.2-4.8) vs. 3.8 (3.7-3.9) days, P < 0.0001] compared with Caucasians. After the adjustment for differences in age, gender, comorbidities (using the enhanced Charlson comorbidity index), hospital location/teaching status, and socio-economic factors, all differences were significantly attenuated or eliminated. Additionally, the adjusted risk was lower in AA compared with Caucasians, for cardiogenic shock [odds ratio (OR) 0.61 (0.47-0.78), P < 0.0001], mechanical ventilation [OR 0.8 (0.70-0.92), P = 0.002] and intraaortic balloon pump insertion [OR 0.63 (0.41-0.99), P = 0.04]. Conclusions Our investigation is the first large US-wide analysis studying racial variations in TC outcomes. AA overall have more in-hospital complications; however, the differences are driven by racial disparities in demographics, comorbidities, and socio-economic factors.
引用
收藏
页码:1056 / 1063
页数:8
相关论文
共 50 条
  • [41] Outcomes of Takotsubo cardiomyopathy in hospitalized cancer patients
    Joy, Parijat Saurav
    Guddati, Achuta Kumar
    Shapira, Iuliana
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2018, 144 (08) : 1539 - 1545
  • [42] Predictors of poor outcomes in patients with Takotsubo cardiomyopathy
    Sadiq, I.
    Weinsier, S.
    Linsky, R.
    Regnante, R.
    Ahmed, H.
    Lateef, S.
    Gordon, P.
    EUROPEAN HEART JOURNAL, 2008, 29 : 151 - 151
  • [43] Gender and Race Differences in Patient Characteristics and Outcomes in 10,582 Hospitalizations for Takotsubo Cardiomyopathy
    Kao, David P.
    Lindenfeld, JoAnn
    CIRCULATION, 2014, 130
  • [44] Racial Breakdown of Sickle Cell Disease Complications and Hospitalization Outcomes: Nationwide Inpatient Sample
    Franco, Diana
    Farooq, Umer
    Franco, Jorge
    Espinoza-Gutarra, Manuel Ricardo
    BLOOD, 2022, 140 : 2582 - 2583
  • [45] Epidemiology and outcomes of peripartum cardiomyopathy in the United States: findings from the Nationwide Inpatient Sample
    Krishnamoorthy, Parasuram
    Garg, Jalaj
    Palaniswamy, Chandrasekar
    Pandey, Ambarish
    Ahmad, Hasan
    Frishman, William H.
    Lanier, Gregg
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2016, 17 (10) : 756 - 761
  • [46] GENDER DIFFERENCES IN BURDEN OF ARRHYTHMIAS IN PATIENTS WITH TAKOTSUBO CARDIOMYOPATHY
    Pant, Sadip
    Deshmukh, Abhishek
    Hayes, Kevin
    Badheka, Apurva O.
    Dabhadkar, Kaustubh
    Tuliani, Tushar
    Paydak, Hakan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E348 - E348
  • [47] Effect of ethninicty on in-hospital outcomes of takotsubo cardiomyopathy, data from the national inpatient sample database
    Zaghlol, R.
    Desale, S.
    Barac, A.
    EUROPEAN HEART JOURNAL, 2019, 40 : 1359 - 1359
  • [48] Sex Differences in Stress-Induced (Takotsubo) Cardiomyopathy
    Maskoun, Waddah
    Alqam, Bilal
    Habash, Fuad
    Gheith, Zaid
    Sawada, Stephen G.
    Vallurupalli, Srikanth
    CJC OPEN, 2023, 5 (02) : 120 - 127
  • [49] Non-Whites Suffer Worse Outcomes in Takotsubo Cardiomyopathy Than Whites: An Analysis of Racial/Ethnic Disparities
    Bhuva, Rushik
    Desai, Rupak
    Fong, Hee Kong
    Zalavadia, Dipen
    Siddiq, Wardah
    Gupta, Sonu
    Omar, Ahmed
    Dammalapati, Tirumala Rao
    Sachdeva, Rajesh
    Kumar, Gautam
    CIRCULATION, 2018, 138
  • [50] A Nationwide Population-Based Study of Racial Differences in the Outcomes of Necrotizing Pancreatitis Hospitalizations
    Ogwor, Oghenefejiro
    Omaliko, Chidiebele
    Olafimihan, Ayobami
    Ezeani, Chukwunonso B.
    Oredipe, Omotola
    Ibe, Festus
    Ugwu, Chidiebube J.
    Okeke, Chukwuemelie
    Gorrell, Sarah M.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S101 - S101